Biosimilar Filgrastim in Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization and Post-Transplant Hematologic Recovery

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|21|2217-2229

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.21, 2016-08, pp. : 2217-2229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lenograstim: A Review of its Use in Chemotherapy-Induced Neutropenia, for Acceleration of Neutrophil Recovery Following Haematopoietic Stem Cell Transplantation and in Peripheral Blood Stem Cell Mobilization

By Keating Gillian M.  

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 679-707

Adis International

Access to resources Recommend Favorite

Costs of Peripheral Blood Progenitor Cell Transplantation Using Whole Blood Mobilised by Filgrastim as Compared With Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphoma

By Uyl-de Groot C.A.  

PharmacoEconomics, Vol. 15, Iss. 3, 1999-03 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response

By Rifkin Robert  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 714-722

Springer Publishing Company

Access to resources Recommend Favorite

Busulfan in hematopoietic stem cell transplant setting

By McCune Jeannine S   Holmberg Leona A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 957-969

Informa Healthcare

Access to resources Recommend Favorite

Sexual health in hematopoietic stem cell transplant recipients

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4124-4131

Blackwell Publishing

Access to resources Recommend Favorite